Navigation Links
HIV home testing kits prove their worth
Date:8/20/2012

Thirty years into the HIV epidemic, many people who are at high risk of HIV infection cannot or will not adopt safer sexual practices, such as abstinence and condom use. This means there is room in the market for alternative methods to reduce either exposure to or transmission of HIV among these individuals. One such strategy, HIV home testing (HT), is the subject of a recent study by Alex Carballo-Dieguez and his colleagues at the HIV Center for Clinical and Behavioral Studies at New York. Their work appears online in the journal AIDS and Behavior published by Springer.

A number of biomedical strategies for the prevention of HIV transmission are being developed, many of which are costly and have limited success. Although rapid HIV tests have been available for some time, their potential as a screening tool for possible partners has not yet been studied. And now the possibility of screening partners is a reality with recent FDA approval of HT. Would individuals who choose to have unprotected sex be willing to use them and/or would they ask potential casual partners to take the tests before having unprotected sex?

Twenty-seven ethnically diverse men who have sex with men (MSM) completed the study. They were each given 16 HT kits to use with prospective sexual partners and were monitored weekly for three months and then interviewed in depth. Overall, the HT kits had a high level of acceptability with all men, including ethnic minority MSM, whose infection rates are high. Most men in the study wanted to continue to use these kits and to be able to buy them over the counter.

The in-depth interviews provided the most revealing insights into the significance of the HT kits. Often just the suggestion of using the kit opened up discussion about HIV status when it might not have been mentioned otherwise. In two cases, disclosure of an HIV-positive status was only given once the participant had proposed using the HT kit. Refusal to take the test prompted suspicion in participants who then either had sex with a condom or did not have sex with that potential partner. A positive HIV test resulted in no sex taking place.

Critics of the kits fear that their availability will reduce condom use. However, Carballo-Dieguez and his colleagues contend that it cannot impede condom use in those who already choose not to use condoms. In these individuals, HT would not replace an existing strategy but fill a gap where there is none. It is clear that in this study, HT proved to be a cost-effective, simple and acceptable tool to help prevent the spread of HIV infection in a high risk group.

The authors conclude that, importantly, "since the tactic is peer driven, it may empower individuals to take control of their behavior, develop a non-condom-based approach for communal, shared responsibility to prevent HIV transmission, and ultimately transform serosorting from a guessing game into a strategy based on objective evidence."


'/>"/>
Contact: Janine Haubenreisser
janine.haubenreisser@springer.com
49-622-148-78414
Springer
Source:Eurekalert

Related medicine news :

1. By studying animal health, researchers find improved ways for developing, testing cancer therapies
2. Heterogeneous ER+ breast cancer models allow more accurate drug testing
3. What would happen without PSA testing?
4. HPV testing in HIV-positive women may help reduce frequent cervical cancer screening
5. Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
6. Wednesday Is National HIV Testing Day
7. Experts recommend men at risk for osteoporosis undergo bone density testing
8. Guidelines Issued for When Docs Should Order Vascular Testing
9. Proposed testosterone testing of some female olympians challenged by Stanford scientists
10. DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines
11. Psychological testing may predict success in soccer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of year ... Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer ... Cundiff. , “We are honored to support a promising young investigator from Dr. Lengyel’s ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Early this week, ... and raise awareness of Nestlé KITKAT as the first global confectionery brand sourced from ... cocoa farmers and the quality of their product, through activities that focus on better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
Breaking Medicine Technology: